最後更新 2024-05-14 07:27:02 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

-2%


截至2024-03-31

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

Illumina, Inc. 提供基因和基因組分析的测序和基于陣列的解決方案。其產品和服務為各種市場的客戶提供基因組解決方案在研究和臨床環境中的應用,包括生命科學、腫瘤學、生殖健康、農業和其他新興領域。該公司提供用於基因分析的儀器和耗材;基因分型和测序服務、儀器服務合同和開發和授權協議,以及癌症檢測測試服務。其客戶包括基因組研究中心、學術機構、政府實驗室和醫院,以及製藥、生物技術、商業分子診斷實驗室和消費者基因組公司。該公司直接向北美、歐洲、拉丁美洲和亞太地區的客戶銷售和分銷其產品,並通過生命科學分銷商在歐洲、亞太地區、拉丁美洲、中東和非洲的各個市場銷售。該公司成立於1998年,總部位於加利福尼亞州聖地亞哥。

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Diagnostics & Research

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning